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ABSTRACT
Background and objective Utilities (values representing
preferences) for healthcare priority setting are typically
obtained indirectlyby asking patientsto fill in a qualityof
life questionnaire and then converting the results to a
utility using population values. We compared such
utilities with those obtained directly from patients or the
public.
Design Review of studies providing both a direct and
indirect utility estimate.
Selection criteria Papers reporting comparisons of
utilities obtained directly (standard gamble or time trade
off)orindirectly(Europeanqualityoflife5D[EQ-5D],short
form 6D [SF-6D], or health utilities index [HUI]) from the
same patient.
Data sources PubMed and Tufts database of utilities.
Statistical methods Sign test for paired comparisons
between direct and indirect utilities; least squares
regression to describe average relations between the
different methods.
MainoutcomemeasuresMeanutilityscores(ormedianif
means unavailable) for each method, and differences in
mean (median) scores between direct and indirect
methods.
Results We found 32 studies yielding 83 instances where
directandindirectmethodscouldbecomparedforhealth
states experienced by adults. The direct methods used
werestandardgamblein57casesandtimetradeoffin60
(34 used both); the indirect methods were EQ-5D (67
cases), SF-6D (13), HUI-2 (5), and HUI-3 (37). Mean utility
values were 0.81 (standard gamble) and 0.77 (time trade
off) for the direct methods; for the indirect methods: 0.59
(EQ-5D), 0.63 (SF-6D), 0.75 (HUI-2) and 0.68 (HUI-3).
Discussion Direct methods of estimating utilities tend to
result in higher health ratings than the more widely used
indirect methods, and the difference can be substantial.
Use of indirect methods could have important
implications for decisions about resource allocation: for
example, non-lifesaving treatments are relatively more
favouredincomparisonwithlifesavinginterventionsthan
when using direct methods.
INTRODUCTION
For resources to be allocated fairly, according to bene-
fit gained per unit cost, between different patient
groups, health economists and policy makers use a
common currency of benefit. This standardisation is
usually done by attaching different utilities (also
known as preference weightings, health state values)
to different health states.
1 Utilities are captured on a
scale where 1 represents perfect health, 0 represents
death, and states worse than death have negative
values.
Measurementofutilitiesisatrickyandcontroversial
area. Broadly, two groups of methods exist (fig 1). The
first is based on mapping preferences directly onto the
utility scale. This can be done by means of a trade off
(standard gamble or time trade off) or visual analogue
scale, which is less favoured.
23 We refer to these as
direct measures of utility.
The second is based on mapping preferences onto
the utility scale indirectly via a generic health related
quality of life questionnaire (such as European quality
of life five dimensions [EQ-5D], short form six dimen-
sions [SF-6D], and health utilities index mark 2
[HUI-2] and mark 3 [HUI-3]). Questionnaire
responses are converted to utilities by means of “tar-
iffs” or “weights.” These tariffs are available as a result
of separate and previous exercises in which various
possible health states have been calibrated by means
of a trade off method from a sample of the general
population.Werefertothisgroupofmethodsasindir-
ect methods of utility measurement.
4-7
Indirect methods bypass the time consuming pro-
cessofaskingrespondentstotradehealthstatesfordif-
ferent risks of death (or years of remaining life) each
time a study is carried out; such trade offs need be
done only once and the results obtained can thereafter
beusedtoderiveutilitiesusingasimplequestionnaire.
The indirect methods encountered in this study are
summarised in table 1.
The time trade off and standard gamble interviews
must be implemented by a trained interviewer who
explains the concept clearly without distressing or
leading the patient. By comparison, questionnaires
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and stratifydata into a number of differentdimensions
that the direct methods do not register (such as mobi-
lity and pain).
It is well known that different methods of utility esti-
mation yield systematically different values.
8-14 Stan-
dard gamble, time trade off, and visual analogue scale
have all been compared across studies in a systematic
way.
15-21 However, the relation between direct and
indirect utility measures has not been systematically
documented across studies, despite the fact that differ-
ences between them have been identified in particular
examples.Suchexampleshavecontributedtoawidely
held impression among health economists that direct
methods tend to yield higher utilities (reflecting better
reportedhealth)forgivenhealthstatesthandoindirect
methods, irrespective of the type of direct or indirect
method used (for example, time trade off versus stan-
dardgambleorEQ-5D versusSF-6D).Theaimsofthe
currentstudyweretherefore:tosystematicallyconfirm
or refute the impression that direct methods tend to
yield higher utility values than indirect methods; to
quantify the magnitude of any such differences; and
to describe the relation between direct and indirect
measures.
Data were collected by searching systematically for
studies in which the same respondents completed a
direct trade off and a generic quality of life question-
naire leading to an indirect utility assessment. In view
of the acknowledged differences among the various
direct and indirect methods, we examined our results
overall and by subgroups based on the specific meth-
ods used.
Previous studies have shown that health state valua-
tions obtained directly from affected populations are
often higher (that is, health is rated as better) than
those obtained from unaffected populations asked to
make hypothetical judgments.
2223 For this reason we
supplementedholisticcomparisonsofdirectandindir-
ect methods with an analysis stratified by the type of
population.
METHODS
Literature search
We obtained studiesfrom twosources.As the primary
method,the searchstringsin table 2were usedtolook
for papers in the PubMed databases (covering all dis-
eases) that mentioned a direct and an indirect method
inthetitleorabstract.Wethenlookedateacharticleto
identify those in which the same group of patients had
contributed direct utilities and had completed a health
relatedqualityoflifequestionnaire,theresultsofwhich
had been translated into indirect utilities by means of
pre-existing tariff values.
To verify the primary method, we also reviewed the
Tufts database of utilities
24 for any studies that com-
paredtheutilitieswithinthesamegroupofrespondents.
As a further check that our search strategy had not
missed important studies, we searched PubMed (using
the strings shown in table 3) for studies mentioning all
Direct Indirect
Time trade off: The respondent expresses
indifference between, say, 10 years with a specific
health condition and a period x in perfect health
Utility of health condition = x/10
Standard gamble: The respondent expresses
indifference between (a) the certainty of a specific
health condition and (b) a risk y of immediate
death followed by life in perfect health
Utility of health condition = 1–y
Patient in health condition fills in
quality of life questionnaire (e.g. EuroQol-5D)
Study of unaffected members of the
population provides conversion tables to
transform quality of life scores to utilities.
Utility of health condition
Fig 1 | Direct versus indirect methods of utility elicitation See Brazier et al, 1999.
25
Table 1 |Indirect methods of utility assessment contributing to this study
Utility measurement Description of questionnaire* Tariff weighting obtained
Range of possible
utility scores Comment
European quality of life
five dimensions (EQ-5D)
Five dimensions
(mobility; self-care; usual activities; pain/
discomfort; anxiety/depression), each of which is
assignedone ofthree levels,yielding 243 possible
combinations, each describing a particular health
state
Sample of European general
population (n=3395);
time trade off valuation;
hypothetical scenarios
−0.59 to 1.00 PrecededbyEQ-6D;mostlyusedin
continental Europe and the UK
Short form
six dimensions (SF-6D)
Six dimensions (physical functioning; role
limitations;socialfunctioning;pain;mentalhealth;
vitality),withfourtosixlevels,whichdefine18000
health states.
Sample of UK general population
(n=611);
standard gamble valuation;
hypothetical scenarios
0.30 to 1.00 Derived from the longer SF-36;
applicable to SF-12 and SF-36
Healthutilitiesindexmark2(HUI-2) Seven dimensions (sensory; mobility; emotion;
cognitive;self-care;pain;fertility),withthreetofive
levels, which define 24 000 health states
Parents of unaffected
schoolchildreninOntario,Canada
(n=203); visual analogue scale
transformed into standard
gamble†; hypothetical scenarios
−0.03 to 1.00 HUI-2 originally used to capture
quality of life in children;
mostly used in Canada
Healthutilitiesindexmark3(HUI-3) Eight dimensions (vision; hearing; speech;
ambulation; dexterity; emotion; cognition; pain),
withfive to sixlevels, which define 972 000health
states
Representative sample of adults
in Ontario, Canada (n=504);
visualanaloguescaletransformed
into standard gamble†;
hypothetical scenarios
−0.36 to 1.00 CloselyrelatedadaptationofHUI-2,
with a more detailed descriptive
system;
mostly used in Canada
*Dimensions used in indirect methods of assessment are sometimes referred to as multi-attribute utility scales (MAUSs). For further information see Brazier.
25
†Transformation carried out using conversion factors established in earlier studies.
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utility measures are commonly made: asthma, dia-
betes, rheumatoid arthritis, and stroke. We then scruti-
nised studies to find out whether they compared direct
and indirect methods in the same group of people.
The methodologies used to obtain “tariffs” (weight-
ings to convert the results of health related quality of
life questionnaires to utilities) for the four indirect
methods included among the comparative studies
identified by our search have already been
reviewed.
25 The methods used were time trade off in
the case of EQ-5D, standard gamble in the case of SF-
6D, and a visual analogue scale that was transformed
into a standard gamble (using a conversion factor
obtained in other studies) in the case of HUI.
Data extraction
Eacheligiblestudywasscrutinisedbytwoauthors(DA
and AG) and the following information was extracted:
title,authors,date,diseasetopic,themethodsofelicita-
tion of direct utilities (standard gamble, time trade off,
or both); the generic questionnaires used (EQ-5D, SF-
6D, HUI-2, HUI-3). Mean utility values for each
method, with sample sizes, were extracted for the dis-
easestatesineachincludedstudy.Medianswereextra-
cted when means were not reported. Standard
deviations were recorded if they were available or
could be deduced by working back from cited confi-
dence intervals. Each study was classified according
to whether the respondents were actual patients with
direct experience of a certain condition (we refer to
these as “current patients”) or were asked to imagine
the experience of the condition (“hypothetical
patients”).
Statistical methods
Many of the studies contained data on more than one
health or disease state. Where the same state had been
assessed by separate groups of respondents (for exam-
ple, baseline assessments in the two arms of a rando-
mised controlled trial) these groups retained their
identity in the analysis. In studies where the same
group of respondents had provided utilities for more
than one state, these states were combined (within a
study) by pooling the data to ensure independence
between different groups contributing to the analysis.
This process entailed calculating “average medians”
for studies that did not cite means. The end result was
that each of the independent groups contributed a sin-
gle mean (or median) observation on each of several
utility methods. Differences between the utility obser-
vations obtained in this way cannot be relied on to fol-
low a constant distributional form, even if they could
be attributed to chance alone. Thus the sign test was
used for paired comparisons of direct and indirect
methods.
Average relations between direct and indirect utili-
ties across the independent groups were fitted using
least squares regression lines, with the constraint that
allmethodsassignthevalue1toperfecthealth.Ineach
case the scores from the direct method were regressed
on the scores from the indirect method, to test the
hypothesis that direct utilities could be predicted by
applying a linear correction to the indirect utilities.
The predictive value of the fitted lines was assessed
using an approximate method. Residuals about the
fitted line were calculated and standardised with
respect to variation between subjects (in both utilities).
The method used only those studies that contributed
means and standard deviations to the data set. The lat-
ter were converted to standard errors. Where a group
had been formed (as described above) by pooling
values over different health states, average standard
errors were used—guaranteed to be greater than the
true standard errors in the presence of (unknown) cor-
relations between states. For most studies it was not
possible to estimate residual standard deviations accu-
rately because the correlations between direct and
indirect utilities were not available. Instead, a conser-
vative approach was employed, leading to underesti-
mates of the absolute magnitude of the standardised
residuals.Forafittedliney=a+bxthestandardisedresi-
dual for the point (x′,y′) with standard errors (sx,sy) was
estimated as (y′−a−bx′)÷(sy+|b|sx). The denominator of
thisexpressionisguaranteedtobegreaterthanthetrue
residual standard deviation. We applied χ
2 tests to the
sums of squares of the estimated standardised resi-
duals. The approximations described here mean that
these tests are conservative—they understate the
Table 2 |Search strings used for studies where direct and indirect utilities were compared in
the same population
Search Direct terms used Indirect terms used
Total number
of hits
Hits that
fulfilled criteria
1 Standard gamble or SG EuroQol or EQ-5D or EQ5D 58 15
2 Time trade off or TTO EuroQol or EQ-5D or EQ5D 91 18
3 Standard gamble or SG Short Form or SF-6D or SF6D 88 3
4 Time trade off or TTO Short Form or SF-6D or SF6D 52 5
5 Standard gamble or SG Health utilities index or HUI 116 9
6 Time trade off or TTO Health utilities index or HUI 46 8
Table 3 |Verification search strings used and hits returned
Disorder Search strings All Hits
Contained empirical
utility data
Comparisons within
same population
Relevant hits not found
with original search
Asthma Utilit* Asthma Health 126 15 1 0
Diabetes Utilit* Diabetes Health 437 58 1 0
Rheumatoid arthritis Utilit* Rheumatoid Arthritis Health 156 32 5 0
Stroke Utilit* Stroke Health 295 22 0 0
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thefittedlines.SmallPvaluesindicatethatsuchdiscre-
pancies cannot reasonably be attributed to variation
between the respondents contributing to the same
study.
RESULTS
The main search for studies that contained direct and
indirect methods of comparison returned 32 studies.
The Tufts database search did not yield any studies
comparing direct and indirect utilities in the same
population that had not been retrieved by the original
search. The same was true for the disease specific
search (table 3). Four of the 32 studies were about
health states experienced by children. In three of
these studies, parents had stood as proxies to provide
preference values for their own children. The other
study asked young children to rate their own health,
but the investigators acknowledged methodological
difficulties that could have compromised the results.
The four studies of children were excluded from
further consideration.
Thisleft28studiesforanalysiscoveringawiderange
of diseases (including rheumatic, neuropsychiatric,
vascular, respiratory, gastrointestinal, renal, and infec-
tious diseases) and encompassing data from 4688
respondents.Somestudiesreportedutilitiesforseveral
different states of health or disease. Altogether there
were83instancesinwhichdirectandindirectmethods
could be compared. Sixty-eight of the 83 comparisons
(from 25 studies) were based on current patients, and
15 (from three studies) were based on hypothetical
patients (one group from the general public, two
groups from the healthcare community).
Thefulllistofpapers,includingthoseinvolvingchil-
dren, is given in appendix 1, with summary data from
each paper in appendix 2 (see Web Extra material). A
breakdown of the clinical topics investigated (and the
number of disease states per topic) is given in table 4.
Insomeinstancesmorethanonemethodwasusedto
determineutilities.Fordirectutilities,standardgamble
alone wasusedin 23 of the 83 comparisons,time trade
offalonein26,andbothin34.Themostpopularindir-
ect methods were EQ-5D (n=67) and HUI-3 (n=37),
one or both of which figured in all but four of the 83
comparisons. Table 5 shows a breakdown.
The utility values reported by the individual studies
areaveragesoversamplesofrespondents,withsample
sizes ranging from three to 1011 (median 62). Means
andstandarddeviationsofutilityvalueswereavailable
for 26 studies (covering 72 of the 83 available compar-
isons), with the remainder reporting medians only.
Table 6 summarises the distribution of the reported
mean or median utility values, presented by type of
respondent.
More detailed analyses were undertaken for current
and hypothetical comparisons that reported EQ-5D,
HUI-3, or both. Figure 2 shows the differences
between direct and indirect methods for independent
groups of participants.
In figure 2, all but nine of 86 points lie above the
horizontal line, reflecting the tendency for direct
Table 4 |Clinical conditions contributing data to the study
Population and topic
Number
of papers
Number of
disease states
within papers
Current patients
Peripheral vascular disease 4 18
Hepatitis C 1 7
End stage renal failure (on dialysis) 1 4
Chronic renal disease 1 6
Gastrointestinal reflux 2 2
Age related macular degeneration 1 1
Osteoarthritis of hip 1 3
Arthritis (general) 1 1
Rheumatoid arthritis 3 9
Survivors of extreme prematurity 1 2
Motor neurone disease 1 4
Gout 1 1
Systemic sclerosis 1 1
Severe mental disease 1 1
Depression 1 1
Uncomplicated diabetes 1 1
Benign prostatic hyperplasia 1 1
Chronic obstructive pulmonary
disease
11
Oesophageal cancer 1 4
Hypothetical patients
Supportive care, non specific 1 6
Breast cancer 1 4
Rheumatoid arthritis 1 5
Total 28 83
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Fig 2 | Bland-Altman plot comparing direct and indirect utilities
for average health states within independent groups of
participants. Vertical axis represents half the difference in
utilities; horizontal axis is the average of the two utilities.
Broken lines enclose the feasible region for utilities
constrained to lie between 0 and 1. The single point outside
this region represents a state with a negative EQ-5D estimate.
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spread of the differences diminishes for states
approaching perfect health, a consequence of the fact
that utility estimates cannot be greater than 1. The
direct methods (time trade off, standard gamble) pro-
duced significantly higher values than the indirect
methods (EQ-5D, HUI-3) in every case where a statis-
ticalcomparisonwasfeasible(table 7).Bycontrast,the
differences in utility values between each of the direct
methods and between each of the indirect methods
were not statistically significant.
The discrepancy between individual direct and
indirect measures is reflected in figure 3. These plots
are constructed using information taken directly from
the studies, without aggregation into independent
groups. If direct and indirect methods gave the same
results, then the points would be distributed equally
above and below the 45° line in each panel. The great
majorityofpointsinallpanels,however,fellabovethis
line. In each panel, the broken line represents the pre-
dicted direct utility score from a regression on the
indirect score, as computed from the “current patient”
comparisons. Table 7 shows the slopes for these lines
and those based on hypothetical comparisons. The
linesrepresentaveragerelationsonly,withstatistically
significant (P<0.05) departures from the line in all but
one instance, which was based on very low sample
numbers. This finding suggests that the variation
between participants within studies was not sufficient
to account for the discrepancies between the plotted
points and the fitted lines. At best, these lines charac-
terise “average” relations between direct and indirect
methodsacrossa collection ofdifferent healthstates; it
cannotbeassumedthattheywillproduceaccuratecon-
versions from one type of utility to another.
DISCUSSION
Principal findings
Our findings show that the versatile and convenient
indirectmethodsofutilitymeasurementyielddifferent
resultsfromthoseobtainedbythedirectmethods.The
indirect methods yielded systematically lower utility
valuesthandirectmethodsforawiderangeofdiseases
(we give two examples in the box). The differences in
utility values between the direct and indirect groups of
methodsweresometimessubstantial,andtendedtobe
greater than the differences between the individual
methods making up the group.
Limitations
As with all systematic reviews, the results are con-
strained by the published literature which, in this
case, gave access to 83 comparisons across 28 studies.
The studies covered many different diseases and sev-
eral different methods of utility elicitation allowing a
general trend to be identified—that indirect methods
tend to yield lower utilities than direct methods. How-
ever,theheterogeneityofmethodsanddiseasestatesin
thereviewprecludesanygeneralisablenumericalsum-
mary of effect size that would apply to a different spec-
trum of patients or methods.
Explaining the findings
Thisstudywasnotdesignedtoelucidatethereasonsfor
the differences in results between indirect and direct
methods. Nevertheless, there are several possible
explanationsthatcouldcontributetoanunderstanding
of the results.
One potential explanation is that the generic ques-
tionnaires used to obtain the indirect utilities impose
constraints: respondents are forced to encapsulate
their potentially complex condition within five to
eight categories, depending on the questionnaire
used. The questionnaires do not allow respondents to
report, for example, potentially positive aspects of
their situations that would boost utility values. There
is a risk, therefore, that people contributing tariffs for
the various states form a different impression to that
which those completing the questionnaire would
have had.
Table 5 |Breakdown of indirect methods used
Numbers of indirect methods
EQ-5D
(N=67)
SF-6D
(N=13)
HUI-2
(N=5)
HUI-3
(N=37)
Numbers of
comparisons
One (N=48)
√ ——— 37
— √ —— 4
———√ 7
Two (N=31)
√ —— √ 24
√√—— 5
——√√ 2
Three (N=4)
√√— √ 1
— √√√ 3
Total ———— 83
Table 6 |Distribution of preference values across all disease states assessed by included studies
Current patients* Hypothetical patients Overall
mean (SD) Studies States Range Mean (SD) Studies States Range Mean (SD)
Time trade off 19 50 0.52, 0.99 0.83 (0.10) 2 10 −0.17, 0.77 0.45 (0.27) 0.77 (0.20)
Standard gamble 16 46 0.45, 1.00 0.83 (0.12) 2 11 0.47, 0.90 0.70 (0.14) 0.81 (0.14)
EQ-5D 19 52 −0.01, 0.93 0.65 (0.15) 3 15 −0.52, 0.81 0.35 (0.34) 0.59 (0.24)
SF-6D 6 13 0.55, 0.69 0.63 (0.04) —— — — 0.63 (0.04)
HUI-2 2 5 0.55, 0.95 0.75 (0.17) —— — — 0.75 (0.17)
HUI-3 10 37 0.34, 0.89 0.68 (0.11) —— — — 0.68 (0.11)
Each disease state is associated with just one study. The statistics in each row (mean, SD, range) refer to the sample of disease states.
*The majority of studies reported mean utility values across samples of patients. Two studies of current patients reported only median utilities. These
have been included in the table nevertheless.
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tribute trade off values for indirect utility elicitation
differ systematically from the patients that participate
in direct methods. The general population used to
obtain tariffs for indirect utility estimation is spread
across a wider age range thanpatient populations typi-
cally used in direct estimation. Young people in good
health and people with diseases may have very differ-
entperspectivesontherelativemeritsofremainingina
given health state and making a trade off involving
death.
Those participating in elicitation of indirect tariffs
are always asked to make a hypothetical choice
whereasdirectutilitiesareusuallybasedontheexperi-
ence of people who actually have the condition, who
are aware not only of the distress of living with a con-
dition, but also of mitigating factors. They may derive
benefitsfromfamily,friends,work,andrecreationona
daily basis and tend, over time, to adapt to their
condition.
26 Members of the general public contribut-
ing tariffs for health states are at a considerable emo-
tional distance—they lack personal experience of the
disease,andthedescriptionsgiveningenericquestion-
naires are rather bland and decontextualised.
25
However, the difference between direct and indirect
utilities seems to remain even when values are elicited
from an (admittedly small) sample of hypothetical
patients. This may be because the verbal “pictures” of
disease used were somewhat richer when applying
direct methods to hypothetical patients than when eli-
citing tariffs for the calibration of indirect methods.
25
Finally, modifications to the methodology for deriv-
ing indirect utilities from quality of life questionnaires
have recently been suggested.
27 If implemented these
would tend to increase the valuations attached to mild
health states and eliminate some of the differences
observed here.
Direct or indirect?
Simply observing a systematic and substantial differ-
ence between methods, as we have done, does not
resolve the decision of which method to choose.
There is, however, no universally accepted theoretical
basis for choosing direct or indirect methods.
1 Some
people think that utilities should be derived from
patients (ideally at stages throughout their illness) on
the grounds that only patients really know what the
condition is like. Others think that the citizen’s per-
spective is more relevant. Various reasons have been
given for this opinion—it is argued that citizens are the
natural(anddemocratic)locusfora decisionaboutuse
of society’s resources, that citizens can be asked to fac-
tor in societal objectives (such as the pursuit of equity),
and that the necessarily hypothetical choices that citi-
zens make conform to “the axioms of utility theory”,
whereby decisions are made prospectively under
uncertainty. However, a preference for direct or indir-
ect utilities does not necessarily result from these con-
siderations:directutilitiesderivedhypotheticallyfrom
citizens and indirect utilities calibrated through a sur-
vey of the general population can both provide the
advantages of the citizen’s perspective.
Given the absence of a gold standard for the elicita-
tion of utilities, it may be informative to consider the
Examples in which indirect methods produce considerably lower utilities than direct
methods
For the condition of intermittent claudication an indirect (EQ-5D) utility of 0.57 was
elicited. This value implies that a person would forgo over 40% of their remaining life or
runslightlyovera40%riskofdeathtoavoidthecondition.Yetthesamerespondentsgave
direct utilities of 0.82 (time trade off) and 0.91 (standard gamble) for the condition. So,
when asked directly, they would only accept a much lower risk (of around 10%) to avoid
the condition.
Forpatientswithchronicobstructivepulmonarydisease,respondentsgaveautilityof0.91
for the direct method (time trade off), accepting a 9% reduction in lifespan to avoid the
condition. The EQ-5D utility from the same patients was 0.73, suggesting a willingness to
forgo a quarter of their remaining lifespan. Readers may wish to consider whether a
preventative treatment with a mortality of 25% would really be acceptable for most
patients destined to develop this disease.
In both these cases, the utilities were taken from current patients.
Table 7 |Pairwise comparisons between and within direct and indirect methods
Comparison
Number
of states
Mean difference
(SD)
Number of independent
groups
Sign
test
Regression
slope (SE)
Predictive
P value
Current patients
Time trade off – EQ-5D 40 0.17 (0.13) 26 P<0.001 0.54 (0.07) P<0.001
Standard gamble – EQ-5D 39 0.20 (0.15) 27 P<0.001 0.50 (0.05) P<0.001
Time trade off – HUI-3 24 0.19 (0.09) 13 P=0.023 0.48 (0.06) P<0.003
Standard gamble – HUI-3 29 0.15 (0.11) 16 P=0.004 0.65 (0.08) P<0.002
Standard gamble – Time trade off 28 0.02 (0.06) 16 P=0.804 ——
HUI-3 – EQ-5D 25 0.03 (0.13) 14 P=0.424 ——
Hypothetical patients
Time trade off – EQ-5D 10 0.13 (0.12) 2 NA 0.81 (0.01) P<0.994
Standard gamble – EQ-5D 11 0.15 (0.11) 2 NA 0.50 (0.06) P<0.042
Standard gamble – Time trade off 6 0.22 (0.05) 1 NA ——
NA=not applicable. Second column shows numbers of states contributing to mean and SD of the difference. Sign tests and regression analyses are
based on aggregate health states obtained from averaging data within independent groups of participants. Regression slopes refer to least squares
lines for predicting direct utility from indirect utility, constrained to pass through the point (1,1). Predictive P-values assess the goodness-of-fit of the
lines, taking variation within studies into account.
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Implications for resource allocation
Hadwefoundlittleornodifferencebetweendirectand
indirect methods, then the latter could be recom-
mended on grounds of efficiency since, once the tariffs
have been set, indirect utilities are far simpler to elicit.
However, it seems that indirect methods give consis-
tently lower levels of utility than direct methods. This
meansthatthereismoreheadroomforutilitygainwith
indirectmethods.Theutilityofdeath,however,isfixed
atzero.Thus,incomparisonwithdirectmethods,indir-
ect methods will favour the allocation of healthcare
resources away from interventions that prevent or
delay death in favour of those that alleviate non-fatal
conditions. It could be argued that the popularity of
indirectmethodsforinformingrationingdecisionssim-
ply expresses a legitimate societal attitude in favour of
non-lethal over lethal conditions. However, it could
equally be argued that the public would rather give
more weight to delaying death. In that case indirect
methods might risk undervaluing both personal and
societal preferences. In England, the National Institute
for Health and Clinical Excellence (NICE) has noted
that“societyplacesgreatvalueonextendingthelivesof
peoplewith life-threateningconditions” and has issued
new guidance for “life-extending treatments that are
above the usual range of cost effectiveness,”
28 in the
wakeofdecisionsthatdeniedlifeextendingtreatments.
We are not the first investigators to suspect that
many of the utilities used in health resource decisions
seem too low, particularly at the upper end of the
scale.
29 If this is so, then the data presented here show
that the tendency applies especially to indirectly eli-
cited utilities (see box).
Implications for decision makers
Those who prefer direct methods, but who wish to
exploit the convenience of indirect methods, might
propose using a simple correction to map indirect uti-
litiesontotheputativelymorevaliddirectutilities.Our
results show that linear adjustments of indirect utilities
can achieve only a partial conversion to direct utility
scores. They cannot be used to accurately predict
direct utilities for particular health states. However,
such an adjustment may be better than nothing,
because the adjusted utilities are well calibrated on
average. Further development in the science of utility
estimation could make a contribution by identifying
the characteristics of disease states for which the aver-
age adjustment is inappropriate.
Thispaperaddsweighttotherecommendationtobe
cautious when using utilities of any type. In the con-
structionofhealtheconomicmodelsitmaybeprudent
toextendtherangeofuncertaintybeyondtheconfines
ofstatisticalconfidencelimitsandconductasensitivity
analysis.Inthatcase,theresultspresentedheresuggest
that indirect utilities might best be used to populate
only the lower limits of such an analysis.
Becausedirectandindirectmethodscanleadtosuch
noticeable differences in elicited utilities, priority set-
ting institutions should avoid using a mixture of meth-
ods for different decisions, otherwise a motivated
choiceofmethodmightbeusedtodistorttheoutcome
inapreferreddirection.NICEhascertainlyhadtodeal
with inconsistent use of methods.
30 It may be that a
general counsel against the mixing of different meth-
ods is the most important implication of this work.
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Fig 3 | Direct utilities against indirect utilities. Plotted points are means (if available) or
medians from health-states within 28 studies. Vertical and horizontal lines represent standard
errors cited (or deduced) within the studies. Broken lines are regressions of direct on indirect
utilities from current patient comparisons. In top left panel, one (hypothetical) point lies off the
scale, with EQ-5D=−0.52, time trade off=−0.17.
WHAT IS KNOWN
Health state utilities play a crucial role in the allocation of healthcare resources
Utilities may beobtaineddirectly(usually frompatients) or, more often,indirectly, byusing a
quality of life questionnaire, the results of which are converted to utilities using “weights”
(tariffs) obtained from the general public
Different direct and indirect methods yield different utility values
WHAT THIS PAPER ADDS
Indirectmethodsasagroupproduceconsistentlylowerutilities(worserecordedhealth)than
the direct group of methods
This difference may be larger than the differences between methods within each group
Reliance on indirect methods will result in less resources being allocated to life saving
treatments than if direct methods were used
Conversion of indirect utilities to direct utilities is only partly successful
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